Article
Mechanistically informed adaptive dosing for cancer immunotherapy using AI-guided decision making
2026-06-12
Abstract excerpt
Optimizing dose and schedule remains a central challenge in oncology drug development, particularly for immunotherapies where fixed dosing regimens often fail to account for patient specific heterogeneity in tumor–immune dynamics. Here, we present a hybrid quantitative systems pharmacology–reinforcement learning–Monte Carlo Tree Search (QSP–RL–MCTS) framework for personalized immunotherapy dosing that formulates d...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4e5f00b5-ce1c-5409-b599-b6158198144d
- DOI
- 10.64898/2026.06.09.730783
